These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18273721)

  • 1. Concurrent use of methotrexate and acitretin revisited.
    Lowenthal KE; Horn PJ; Kalb RE
    J Dermatolog Treat; 2008; 19(1):22-6. PubMed ID: 18273721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
    Smith EC; Riddle C; Menter MA; Lebwohl M
    Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the combined use of methotrexate and acitretin in a dermatology hospital setting.
    Andersson NW; Simonsen AB; Thomsen SF; Zachariae C
    Clin Exp Dermatol; 2021 Aug; 46(6):1103-1105. PubMed ID: 33655584
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
    Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M; Rafiei B; Moosavi ZB; Sina N
    Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
    Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
    Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.
    Rattanakaemakorn P; Pinyowiwat P; Iamsumang W; Chanprapaph K; Suchonwanit P
    Drug Des Devel Ther; 2021; 15():2299-2307. PubMed ID: 34093007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate versus Acitretin in the Treatment of Chronic Hand Dermatitis.
    O'Shea PM; Lugo-Somolinos A
    J Drugs Dermatol; 2015 Dec; 14(12):1389-91. PubMed ID: 26659930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies: rotational therapy and combinations.
    van de Kerkhof PC
    Clin Exp Dermatol; 2001 Jun; 26(4):356-61. PubMed ID: 11422189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [News on psoriasis from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
    Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-betamethasone weekly oral pulse in psoriasis.
    Gupta R; Gupta S
    J Dermatolog Treat; 2007; 18(5):291-4. PubMed ID: 17852636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.